中国肿瘤生物治疗杂志2015，Vol.22Issue(6)：690-695,6.DOI:10.3872/j.issn.1007-385X.2015.06.003
舒尼替尼促进HepG2细胞NKG2DLs表达从而增强NK细胞杀伤活性
Sunitinib increases the expressions of NKG2DLs on human hepatocellular carcinoma HepG2 cells and enhances the cytotoxic action of NK cells
摘要
关键词
舒尼替尼/肝癌细胞/自然杀伤细胞/自然杀伤细胞2族成员D/杀伤活性Key words
sunitinib/hepatocellular carcinoma/natural killer (NK) cell/natural killer group 2 member D (NKG2D)/killing activity分类
医药卫生引用本文复制引用
黄宇贤,陈心彤,林遐,翁关样,李玉华,吴秉毅,宋朝阳,郭坤元..舒尼替尼促进HepG2细胞NKG2DLs表达从而增强NK细胞杀伤活性[J].中国肿瘤生物治疗杂志,2015,22(6):690-695,6.基金项目
国家自然科学青年基金资助项目(No.81302372,81300431) （No.81302372,81300431）
南方医科大学珠江医院优秀中青年人才项目资助(No.201207008) .Project supported by the National Natural Science Foundation for Young Scientists of China (No.81302372,81300431),and the Excellent Middle and Yong Aged Experts Project of Zhujiang Hospital Southern Medical University(No.2012007008) （No.201207008）
